Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Teva | Ibandronic acid | Ibandronic Acid Teva |  | 2010-09-17 |  |  |
Irinotecan | Irinotecan |  | 2008-02-27 |  |  | |
Sandoz | Ibandronic acid | Ibandronic Acid Sandoz |  | 2011-07-26 |  |  |
Irinotecan | Irinotecan |  | 2008-02-27 |  |  | |
Bayer | Larotrectinib | Vitrakvi | 2029-10-21 | 2018-11-26 |  |  |
Recordati | Mechlorethamine | Mustargen |  | 1982-01-01 |  |  |
Helsinn Birex Pharmaceuticals | Mechlorethamine | Valchlor | 2026-03-07 | 2013-08-23 |  |  |
Amgen | Denosumab | Xgeva |  | 2011-07-13 | $2,191 M | Q4/23-Q3/24 |
Seagen | Tucatinib | Tukysa |  | 2021-02-11 | $374.499 M | Q4/22-Q3/23 |
Atnahs Pharmaceuticals | Ibandronic acid | Bondronat |  | 1996-06-25 |  |  |
Novast Laboratories | Irinotecan | Irinotecan |  | 2017-05-26 |  |  |
Cipla | Irinotecan | Irinotecan |  | 2008-02-20 |  |  |